Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tata

Showing results (1271-1280 of 1,326) with videos related to

Pageof 133
Sort By:
Plos One|June 2, 2023
The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, UgandaK Kasonia, D Tindanbil, J Kitonsa, et al.
Nature|December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccinationRama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitorsThomas H Graham, Hong C Shen, Wensheng Liu, et al.
International Journal of Antimicrobial Agents|April 29, 2026
Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trialIgnacio Perez-Valero, Diana Corona Mata, María Jose Crussells Canales, et al.
Journal of Proteomics & Bioinformatics|April 1, 2016
Gene Expression Profiling of Gastric CancerArivusudar Marimuthu, Harrys K C Jacob, Aniruddha Jakharia, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Science Signaling|October 25, 2022
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replicationTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Agonist lead identification for the high affinity niacin receptor GPR109aTawfik Gharbaoui, Philip J Skinner, Young-Jun Shin, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Pageof 133

Showing results (1271-1280 of 1,326) with videos related to

Sort By:
Pageof 133
Plos One|June 2, 2023
The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, UgandaK Kasonia, D Tindanbil, J Kitonsa, et al.
Nature|December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccinationRama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitorsThomas H Graham, Hong C Shen, Wensheng Liu, et al.
International Journal of Antimicrobial Agents|April 29, 2026
Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trialIgnacio Perez-Valero, Diana Corona Mata, María Jose Crussells Canales, et al.
Journal of Proteomics & Bioinformatics|April 1, 2016
Gene Expression Profiling of Gastric CancerArivusudar Marimuthu, Harrys K C Jacob, Aniruddha Jakharia, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Science Signaling|October 25, 2022
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replicationTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Agonist lead identification for the high affinity niacin receptor GPR109aTawfik Gharbaoui, Philip J Skinner, Young-Jun Shin, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Pageof 133